Clinical Drug: Monoclonal antibodies

Medical news and research articles

Genetic marker may flag severe IBD earlier in some patients

In the largest genetic study of inflammatory bowel disease (IBD) traits to date, researchers have identified a genetic marker associated with more severe ulcerative colitis and Crohn's disease—the major forms of IBD.

AI model can accelerate antibody drug production

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions. With the market for these therapies forecast to double ...

page 1 from 2